Win EU Drug Tenders Before the Patent Expires: A Business Development Guide for Biopharma Commercial & Market Access Vendors
The Patent Clock Is a Sales Calendar Every drug patent that expires is a starting gun, not a finish line. […]
Can This Drug…Do That? The internet keeps asking. The pharmacology keeps sighing.
There’s a certain genre of drug question that never goes out of style: “Can this thing I’m already taking also
Can This Drug…Do That? The internet keeps asking. The pharmacology keeps sighing. Read Post »
Stop the DIY Search: An Inadequate Drug Patent FTO Opinion Puts You at Risk of Willful Infringement
Courts can triple damages for willful infringement. A flawed freedom-to-operate search is not a defense — it is evidence you
The Real Price of a Drug: A Total Cost of Ownership Model for Pharma Procurement Teams
Unit price is the number everyone fights over. It’s also the number that matters least. Pharmaceutical procurement has a dirty
The Real Price of a Drug: A Total Cost of Ownership Model for Pharma Procurement Teams Read Post »
Drug Patent Term Extensions: How Pharma Turns Extra Time Into Billions
The Clock You Can Buy In the drug industry, time is not just money. It is the only thing that
Drug Patent Term Extensions: How Pharma Turns Extra Time Into Billions Read Post »
The Hatch-Waxman Playbook: How Generic Drugmakers Use Patent Litigation to Get to Market Early
Introduction: The Law That Reshaped American Medicine In 1984, a California congressman named Henry Waxman and a Utah senator named
How to Offer Abuse-Deterrent Reformulation Packages Before Drug Patent Loss of Exclusivity — and Win the Contract
The Problem With Waiting Most formulation vendors approach business development reactively. They wait for a drug to lose exclusivity, watch
Old Drugs, New Signals: What the Side-Effect Conversation is Really Saying
There’s a quiet shift happening in pharmacology that doesn’t show up neatly in prescribing guidelines or FDA labels. It shows
Old Drugs, New Signals: What the Side-Effect Conversation is Really Saying Read Post »
What a Drug Patent Is Really Worth: How Litigation Costs Reshape Acquisition Value
The Number Nobody Puts in the Model Every pharma M&A deal starts with a revenue forecast. Bankers build complex discounted
What a Drug Patent Is Really Worth: How Litigation Costs Reshape Acquisition Value Read Post »
